Viropro, Inc., formed in 2004, focuses on the discovery and development of potential therapeutic monoclonal antibodies directed specifically to disease causing proteins. Company Overview.
Alpha Biologics is a bio-manufacturing organisation offering US FDA and European EMEA current Good Manufacturing Practices (cGMP) compliant services to the worldwide pharmaceutical and biotechnology industry.
“State-of-the-art custom-made manufacturing equipment!”
Viropro International (VPI), a 100% subsidiary of Viropro, ‘houses’ Viropro’s biosimilar technologies and associated technical developments for the purpose of commercialization through external partnerships. Viropro is developing a range of products and manufacturing processes.
“Rituximab (Rituxan®), Trastuzumab (Herceptin®), Infliximab (Remicade®), Etanercept (Enbrel®), Bevacizumab (Avastin®)”